Holecistokininski antagonist (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Holecistokininski antagonist" in Serbian language version.

refsWebsite
Global rank Serbian rank
4th place
8th place
2nd place
4th place

doi.org

  • Rehfeld, JF (2004). „Clinical endocrinology and metabolism. Cholecystokinin”. Best practice & research. Clinical endocrinology & metabolism. 18 (4): 569—86. PMID 15533776. doi:10.1016/j.beem.2004.07.002. 
  • González-Puga, C; García-Navarro, A; Escames, G; León, J; López-Cantarero, M; Ros, E; Acuña-Castroviejo, D (2005). „Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin”. Journal of pineal research. 39 (3): 243—50. PMID 16150104. doi:10.1111/j.1600-079X.2005.00239.x. 

nih.gov

ncbi.nlm.nih.gov

  • Rehfeld, JF (2004). „Clinical endocrinology and metabolism. Cholecystokinin”. Best practice & research. Clinical endocrinology & metabolism. 18 (4): 569—86. PMID 15533776. doi:10.1016/j.beem.2004.07.002. 
  • González-Puga, C; García-Navarro, A; Escames, G; León, J; López-Cantarero, M; Ros, E; Acuña-Castroviejo, D (2005). „Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin”. Journal of pineal research. 39 (3): 243—50. PMID 16150104. doi:10.1111/j.1600-079X.2005.00239.x.